Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil to consider reimbursement reform options

This article was originally published in Clinica

Executive Summary

Brazil's commission for economic affairs (CAE) has been asked by parliament to hold an open consultation on reforming healthcare reimbursement. The project will entail a "systematic reform of the reimbursement of health service providers and their relationship with hospitals, [clinical pathology] laboratories and healthcare programmes", according to a statement by the Senate's public relations office. The CAE, which was formally given the project on September 1, following its approval by the chamber of deputies, is considering the plans, and has yet to announce details of when and how the project will be held.

You may also be interested in...



Resolving Botanicals Deadlock 'Not A Priority' For European Commission

Tensions between industry and the European Commission on the issue of  health claims for botanical food supplements were aired on the second day of the BAH's High Level Conference on the Future of Medicines, with the EC saying the EU Green Deal is now higher up on its list of priorities for the foreseeable future. 

Hikma’s Vascepa Launch Strategy ‘Can Cause Market Confusion’

Issues over supply and the use of a skinny label have the potential to take a toll on the market for the fish oil drug icosapent ethyl, one analyst has claimed in the wake of Hikma’s recent generic launch.

Germany Approves Unified Patent Court Ratification Bill

The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.

Topics

UsernamePublicRestriction

Register

OM016193

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel